Search Results

Eileen Byrne, MSN, CRNP, is a nurse practitioner at Maryland Oncology Hematology. Eileen earned her Bachelor of Science in Nursing from Georgetown University before completing a Master of Science in Nursing at the University of Pennsylvania. She worked in oncology nursing for six years prior to joining the team at Maryland Oncology Hematology. Eileen has…

Mature cancer care patient Tremendous advances are made every day in the fight against cancer, but many promising treatments are costly, placing patients under enormous financial pressure. The challenges of increasing premiums, deductibles, and copayments affect many, with up to 61% of cancer patients facing difficulties in their care.1 Patients in Maryland Have a Choice in Cancer…

Elacestrant versus Standard Endocrine Therapy in Women and Men with Node -positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence – A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)(STML-ELA-0422) MOA: Elacestrant is an oral SERD and ER antagonist. Key Eligibility Criteria: Women or men with confirmed ER-positive (≥10% by IHC), HER2-negative…